Milestone Scientific (Milestone Scientific) Cash Conversion Cycle : 314.55 (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Milestone Scientific Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Milestone Scientific's Days Sales Outstanding for the three months ended in Mar. 2024 was 19.78.
Milestone Scientific's Days Inventory for the three months ended in Mar. 2024 was 437.78.
Milestone Scientific's Days Payable for the three months ended in Mar. 2024 was 143.01.
Therefore, Milestone Scientific's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2024 was 314.55.

Milestone Scientific Cash Conversion Cycle Historical Data

The historical data trend for Milestone Scientific's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Milestone Scientific Cash Conversion Cycle Chart

Milestone Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Conversion Cycle

Get a 7-Day Free Trial

158.40

312.70

159.19

101.74

177.32

Milestone Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Conversion Cycle	Get a 7-Day Free Trial															150.67	148.89	264.63	217.63	314.55

Competitive Comparison of Milestone Scientific's Cash Conversion Cycle

For the Medical Instruments & Supplies subindustry, Milestone Scientific's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Milestone Scientific's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Milestone Scientific's Cash Conversion Cycle falls into.

Milestone Scientific Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Milestone Scientific's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle	=	Days Sales Outstanding	+	Days Inventory	-	Days Payable
	=	18.7	+	266.47	-	107.85
	=	177.32

Milestone Scientific's Cash Conversion Cycle for the quarter that ended in Mar. 2024 is calculated as:

Cash Conversion Cycle	=	Days Sales Outstanding	+	Days Inventory	-	Days Payable
	=	19.78	+	437.78	-	143.01
	=	314.55

Milestone Scientific (AMEX:MLSS) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.

Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.

Milestone Scientific Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Milestone Scientific's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.

Milestone Scientific (Milestone Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Milestone Scientific Inc (AMEX:MLSS) » Definitions » Cash Conversion Cycle

Comparable Companies

Traded in Other Exchanges

N/A

Address

425 Eagle Rock Avenue, Roseland, NJ, USA, 07068

Website

https://www.milestonescientific.com

Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.

Executives

Peter J Milligan	officer: President	1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Neal I Goldman	director	170 SOUTHPORT DRIVE, MORRISVILLE NC 27560
Leslie Bernhard	director	C/O ADSTAR, INC., 488 S. ROYAL LANE, COPPELL TX 75019
Benedetta I Casamento	director	200 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Leonard Osser	director, 10 percent owner, officer: CEO
Leonard M Schiller	director
Scott L. Kahn	officer: Chief Financial Officer	425 EAGLE ROCK AVENUE, SUITE 403, ROSELAND NJ 07068
Giandomenico Trombetta	director, 10 percent owner	CORSO VENEZIA 44, MILAN L6 20121
Joseph D'agostino	officer: CFO & COO	C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Jan Adriaan Haverhals	officer: President	110 WHITE ROCK ROAD, APT. 3304, VERONA NJ 07044
Brent W Johnston	officer: President	C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE SUITE 102, LIVINGSTON NJ 07039
Michael Mcgeehan	director	C/O MILESTONE SCIENTIFIC INC, LIVINGSTON NJ 07039
Edward J. Zelnick	director	C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Daniel S Goldberger	officer: President and CEO	24 CARPENTER ROAD, CHESTER NY 10918
Bp4 S.r.l.	director, 10 percent owner, officer: See Remarks	CORSO VENEZIA 44, MILAN L6 20121